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Previous research has shown that mouse embryonic stem (ES) cells can be induced to form neural cells in adherent monocultures. 
In this study, pluripotent stem (iPS) C5 cells derived from meningeal membranes were converted successfully into neural-like 
cells using the same protocol generally used for ES cells. Meningeal-iPS C5 cells were induced to express neural markers Sox1, 
Sox3, Pax6, Nestin and Tuj1 and to reduce the expression of ES markers Oct4 and Nanog during neural differentiation, and can be 
differentiated into Pax6 and Nestin positive neural progenitors, and further into neuronal, astrocytic, and oligodendrocytic cells. In 
vitro differentiation of iPS cells into patient-specific neural cells could serve as a model to study mechanisms of genetic diseases 
and develop promising candidates for therapeutic applications in dysfunctional or aging neural tissues. Meningeal cells express a 
high level of the embryonic master regulator Sox2, allowing them to be reprogrammed into iPS cells more easily than other so-
matic cells. 
induced pluripotent stem cells, embryonic stem cells, meningeal membranes, neural differentiation, serum-free medium, 
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Neurological disorders, such as Alzheimer’s disease, Park-
inson’s disease and stroke, share a marked pathological 
feature, that is, the loss of a specific spectrum of cell types 
in different areas of the central nervous system (CNS) [1]. 
In most cases, the cause of these disorders is unknown [2]. 
The lack of effective preventative therapies and the limita-
tions of current drug therapies, have led to efforts to de-
velop and implement surgical interventions, such as trans-
plantation therapies [1]. It is possible that appropriate cell 
types, derived from either embryonic stem (ES) cells or 
tissue-specific stem cells, may be used to replace cells lost 
during disease [3–6]. 
Generation of pluripotent stem (iPS) cells, sharing simi- 
                      
*Corresponding author (email: sheng_guoqing@gibh.ac.cn) 
lar properties to ES cells, from somatic cells was first re-
ported by Takahashi and Yamanaka, in 2006 [7]. iPS cells 
derived from individual patients may be useful for drug 
screening or regenerative therapies. Recent publications 
have reported multiple technologies for iPS cell generation, 
including different transcription factor combinations, tissue 
origins and selection methods [8–19]. Although iPS cell 
lines generated independently in various laboratories have 
been shown to express pluripotency genes and to be able to 
differentiate into cell types of all three germ layers, it re-
mains unclear whether iPS cells produced by these different 
reprogramming methods can be therapeutically useful. 
Neural stem cells and meningeal cells expressing a high 
level of the embryonic master regulator Sox2 can be used to 
generate iPS cells more easily [13,20,21]. However, iPS 
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cells derived from meningeal cells are more suitable for cell 
transplantation therapies because of the source limitation of 
neural stem cells. In this work, we investigate neural dif-
ferentiation from mouse meningeal-iPS C5 cells. iPS C5 
cells can be induced to form neural progenitor cells, and 
further differentiate into neurons, astrocytes, and oligoden-
drocytes in a serum-free adherent monoculture system pre-
viously used for neural differentiation from mouse ES cells 
in our laboratory. iPS C5 cells exhibit similar features to ES 
cells in terms of neural differentiation in vitro.  
1  Materials and methods 
1.1  Culture of mouse meningeal-iPS cells 
Mouse meningeal-iPS C5 cells, derived using the methods 
described by Qin et al. [13], were grown on mitomy-
cin-inactivated mouse embryonic fibroblasts (MEFs) at 
37°C and 5% CO2 in standard ES cell medium (containing 
Dulbecco’s Modified Eagle Medium (Gibco), 15% fetal 
bovine serum (PAA), 1 mmol/L l-glutamine (Gibco), 0.1 
mmol/L nonessential amino acids (Gibco), 0.1 mmol/L β- 
mercaptoethanol (Gibco), and 1000 U/mL murine leukemia 
inhibitory factor (LIF) (Invitrogen)). Cells were passaged 
every other day by incubation with 0.05% trypsin and 
0.04% ethylenediaminetetraacetic acid (Gibco) for 5 min at 
37°C. The cultures were gently dissociated and replated at a 
1:3–1:8 split ratio. 
1.2  Neural differentiation from mouse meningeal-iPS  
cells 
For initial neural differentiation, iPS C5 cells were cultured 
without feeder cells on 0.1% gelatin (Sigma)-tissue culture 
plastic for at least 3 passages in standard ES cell medium 
containing LIF. Undifferentiated iPS C5 cells were then 
gently dissociated and plated onto 0.1% gelatin-coated tis-
sue culture plastic at a density of 0.5×104–1.5×104 cells/cm2 
in 1:1 mix of DMEM/F12 (Gibco) supplemented with N2 
(Gibco) and Neurobasal medium (Gibco) supplemented 
with B27 (Gibco). To improve the efficiency of neural con-
version, 1 μmol L–1 all-trans retinoic acid (RA) (Sigma) was 
added to N2B27 medium in the initial 2 d of cell culture. 
Each medium was refreshed every other day. 
1.3  Immunocytochemistry 
Cells were fixed with 4% paraformaldehyde for 10 min, and 
then blocked and permeabilized with 10% FBS and 0.2% 
Triton X-100 for 30 min at room temperature. Primary anti-
bodies were then applied and incubated at 4°C overnight. 
Secondary antibodies anti-mouse Alexa Fluor 488/594 (Invi-
trogen) were applied to cells for 1 h at a dilution of 1:2000. 
Cell nuclei were stained with 1 μg/mL 4, 6-diami- 
dino-2-phenylindole (Sigma). Then the cells were mounted 
with glycerine, and visualized and captured under a confocal 
microscope (Leica). The following primary antibodies were 
used in this work: mouse anti-Oct4 (1:100, Santa Cruz Bio-
technology), rabbit anti-Pax6 (1:200, Abcam), mouse 
anti-Nestin (1:200, Abcam), mouse anti-Tuj1 (1:500, Ab-
cam), mouse anti-MAP2 (1:200, Chemicon, Millipore), 
mouse anti-TH (1:500, Abcam), goat anti-Hb9 (1:200, Santa 
Cruz Biotechnology), mouse anti-GFAP (1:200, Cell Sig-
naling Technology), and mouse anti-O4 (1:50, Stem Cell). 
1.4  Real-time PCR analysis 
Total RNA was isolated using Total RNA Isolation kit 
(Macherey-Magel). The first strand cDNA was synthesized 
with 0.2 mg total RNA in 60 µL using reverse transcriptase 
(TaKaRa) and olig-dgT primer. Real-time PCR analysis was 
performed on a MJR Chromo4 fluorescence quantitative 
PCR instrument (Bio-Rad) using the SYBR Green Premix 
Ex Taq (TaKaRa). The expression level of each gene at 
every checkpoint was normalized to the level of the house-
keeping gene glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). 
2  Results 
2.1  Morphologic changes during neural induction 
The iPS C5 cells were subjected to a multistep protocol for 
differentiation into neural cells (Figure 1). Briefly, iPS C5 
cells were plated at a low density and exposed to RA at a 
concentration of 1 μmol L–1 for the initial 2 d. After that 
cells were transferred into N2B27 medium without any ex-
ogenous growth factors. Undifferentiated iPS C5 cells 
formed colonies with a unique morphology when cultured 
on MEFs (mouse embryonic fibroblasts culture) (Figure 
1(a)). Upon plating and culturing in neural differentiation 
medium, iPS C5 cells gradually adopted neural morphology 
by creating protrusions (Figure 1(d)). 
 
Figure 1  Schematic representation illustrating the sequential steps in the 
neural differentiation of iPS C5 cells. (a) iPS C5 cells were generated from 
mouse meningeal membranes and maintained on MEFs. (b) Subsequently, 
iPS C5 cells were replated and cultured on gelatin-coated plates. (c) iPS C5 
cells were exposed to RA at concentrations of 1 μmol L–1 in the initial 2 d. 
(d) After 6–9 d culture iPS C5 cells gradually create protrusions. Scale bar 
= 50 μm. 
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2.2  Expression of neural-specific genes in iPS C5  
cells-derived neural cells 
To observe the process of iPS C5 cells differentiation, real- 
time PCR was used to evaluate the expression of neuroec-
todermal differentiation markers Sox1, Sox3 and Pax6, 
common neural progenitor marker Nestin, and early neu-
ronal marker Tuj1. Both of these neural markers were 
up-regulated (D1–D6) during monolayer differentiation 
(Figure 2(b)). In contrast, Oct4 (also known as Pou5f1) and 
Nanog, two essential markers for undifferentiated ES cells 
were down-regulated in a time-dependent manner (Figure 
2(a)). These findings confirmed that pluripotent meningeal- 
derived iPS cells were able to convert into neuropotent 
cells. 
2.3  Derivation of neural progenitor cells from mouse  
meningeal-iPS cells 
Immunocytochemistry analysis was used to investigate 
neural differentiation of iPS C5 cells in more detail. Se-
quential images showed time-dependent down-regulation of 
Oct4, which was consistent with real-time PCR results 
(Figures 2(a) and 3). After 6 d culture, most cells were im-
munonegative for Oct4 (Figure 3). In contrast, cells were 
immunopositive for Nestin and Pax6 and showed rosette 
conformations typical of neural progenitor properties at day 
6 (Figure 4). 
2.4  Mouse meningeal-iPS cells generate neurons,  
astrocytes and oligodendrocytes 
Neural progenitor cells are multipotent and can give rise to 
three primary lineages of the CNS—neurons, oligodendro-
cytes and astrocytes [22]. In our protocol, the neuronal pre-
cursors began to express the neuronal markers Tuj1 and 
MAP2 on day 3 (not shown), and most cells showed posi-
tive staining for both markers on day 9 (Figures 5(a) and 
6(a)). Interestingly, TH neurons and the motoneuron marker 
Hb9 also emerged during this period (Figures 5(b) and 
6(b)). However, few astrocytic marker GFAP-positive and  
mature oligodendrocytic marker O4-positive cells were ob-
served after more than 9 d of differentiation in culture (Fig-
ure 7). 
3  Discussion 
Mouse meningeal-iPS C5 cells were successfully converted 
into neural stem cells using a revised protocol based on that 
described by Ying et al. [23] for neural differentiation of 
mouse ES cells. iPS C5 cells can form neural progenitors, 
and further differentiate into neuronal, astrocytic, and oli-
godendrocytic cells, showing that mouse meningeal-iPS 
cells have a potential comparable to that of ES cells. 
Takahashi and Yamanaka [7] demonstrated direct repro-
gramming of somatic cells into a pluripotent state in 2006. 
More recently iPS cells were shown to be able to differenti-
ate into many different cell types, such as hematopoietic, 
osteogenic cells, cardiac cells, adipogenic cells, and endo-
thelial cells. Also, some iPS cell-derived somatic cells have 
already been used in disease models and, in some cases, 
have yielded functional improvement [7,19,24–28]. Re-
cently, iPS cells have been generated through the use of 
different tissues, transcription factor combinations and se-
lection methods. Considering all these different techniques, 
the differentiation ability of iPS cells should be thoroughly 
explored before they are used for in-depth studies [8–19]. 
Qin et al. [13] showed that cells from mouse meningeal 
membranes are highly amenable to generation of iPS be-
cause of the high expression of the embryonic master regu-
lator Sox2. Meningeal-iPS C5 cells express high levels of 
endogenous ES markers, including Nanog, Oct4 (Figures 
2(a) and (3)) and show highly homogeneous and complete 
reprogramming abilities enabling them to be used to pro-
duce chimeras [13]. However, whether meningeal-derived 
iPS cells can be converted into neural cells is still unknown. 
Several reports have shown that iPS cells can be effi-
ciently differentiated into neural types in vitro. Wernig et al. 
[29] have shown that iPS cells generated from mouse fibro-
blasts using 4 transcription factors Oct4, Sox2, Klf4, and  
 
Figure 2  Gene expression analysis by real time-PCR on iPS C5 cells during neural differentiation. (a) The pluripotency markers Oct4 and Nanog were 
down-regulated; (b) conversely, the typical markers of neural progenitors Sox1, Sox3, Pax6 and Nestin were up-regulated.  
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Figure 3  Immunofluorescence analysis showed that expression of Oct4 was down-regulated in a time-dependent manner and was undetectable at day 6. 
Scale bar = 100 μm. 
 
Figure 4  Immunofluorescence analysis showed that iPSC C5 cells were positive for markers of neural progenitors Pax6 and Nestin at day 6. Arrowhead 
denotes the formation of neural tube-like rosette structure. Scale bar = 100 μm. 
c-Myc can be efficiently differentiated into neural precursor 
cells, giving rise to neuronal and glial cell types in vitro and 
functionally integrating into the fetal brain. Miura et al. [10] 
indicate that mouse iPS derived from MEF, TTF and hepa-
tocyte cells can be induced to differentiate into neurons, 
astrocytes and oligodendrocytes both in vitro and in vivo. 
Different human iPS clones also share the same develop-
mental time course as hESCs in response to the same neural 
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Figure 5  After iPSC C5 cells were cultured a in neural differentiation medium for 8–9 d, Tuj1 positive neurons and TH neurons were seen. Scale bar = 
100 μm. 
 
Figure 6  After iPSC C5 cells were cultured a in neural differentiation medium for 8–9 d, MAP2 positive neurons and Hb6 positive motor neurons emerged. 
Scale bar=100 μm. 
 
Figure 7  GFAP positive astrocytes (a) and O4 positive oligodendrocytes 
(b) can be detected at day 9. Scale bar =50 μm. 
induction protocol [30]. Through our strategy, iPS C5 cells 
derived from meningeal membranes can be induced to ex-
press the neural markers Sox1, Sox3, Pax6, Nestin and Tuj1 
in a time-dependent manner, while the ES marker Oct4 was 
promptly silenced during neural differentiation culture. This 
demonstrates that iPS cells are sensitive to the genetic 
switch that characterizes the change in potency of neural 
cells (Figure 2). This conclusion is also supported by the 
immunostaining results of neural markers Pax6 and Nestin 
and the ES marker Oct4 (Figures 3 and 4). Furthermore, like 
ES cells, neural progenitor cells generated from iPS C5 cells 
are multipotent and can give rise to 3 primary lineages of 
the CNS when detected by neuron markers Tuj1 and MAP2, 
astrocytic marker GFAP and oligodendrocytic marker O4 
(Figures 5–7). It is interesting that neurons generated from 
iPS C5 cells are almost always tyrosine hydroxylase (TH) 
positive (Figure 4(b)). Previous studies showed that men-
ingeal cells can induce differentiation of dopaminergic  
neurons from mouse and human ES cells [31]. Polo et al. 
[32] showed that iPSCs retain a transcriptional memory of 
their somatic cell of origin. Taking these views into ac-
count, we consider that TH positive cells generated from 
iPS C5 cells are associated with iPS C5 cells which retain 
some memory of meningeal cells. In our results, the expres-
sion level of Nanog was not decreased linearly (Figure 
2(a)). Miura et al. [10] showed that secondary neurospheres 
derived from MEF-iPS cells contained fewer Nanog-EGFP 
+ cells than those derived from TTF-iPS cells and hepato-
cyte-iPS cells. It seems that the persistent expression of 
pluripotent markers of iPS cell-derived somatic cells was 
associated with different tissues from which iPS cells origi-
nate. However, we think that it may have been caused by 
lentiviruses or retroviruses showing residual transgene ex-
pression during early-passage of iPS cells, because different 
iPS clones generated using the same tissues and transcrip-
tion factor combinations also showed different neural dif-
ferentiation efficiency [30]. 
Previous reports claim that mouse neural stem cells and 
meningeal membranes both express high levels of Sox2 and 
are amenable to induction into iPS [13,20,21]. However, 
meningeal-derived iPS are more suitable for cell transplan-
tation therapies because of the source limitation of neural 
stem cells. Our work shows that iPS C5 cells share the neu-
ral differentiation ability of ES cells. Finally, the in vitro 
neural differentiation of iPS cells provides a new perspec-
tive for studying the cellular and molecular mechanisms of 
early neural system development and generation of patient- 
specific cells for therapeutic applications in dysfunctional or 
aging neural tissues. 
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